GELATIN MICROSPHERES AS A NEW APPROACH FOR THE CONTROLLED DELIVERY OF SYNTHETIC OLIGONUCLEOTIDES AND PCR-GENERATED DNA FRAGMENTS

被引:24
作者
CORTESI, R
ESPOSITO, E
MENEGATTI, E
GAMBARI, R
NASTRUZZI, C
机构
[1] UNIV FERRARA,DEPT PHARMACEUT SCI,VIA FOSSATO MORTARA 19,I-44100 FERRARA,ITALY
[2] UNIV FERRARA,CTR BIOTECHNOL,I-44100 FERRARA,ITALY
关键词
SYNTHETIC OLIGONUCLEOTIDE; PCR-GENERATED DNA FRAGMENT; GELATIN MICROSPHERE; CONTROLLED RELEASE;
D O I
10.1016/0378-5173(94)90464-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present paper reports the preparation and characterization of gelatin microspheres containing (a) a 44-mer single-stranded synthetic oligonucleotide, complementary to the HLA-DRA gene (ssDNA-44) and (b) a double-stranded fragment, 144 bp in length, prepared by the polymerase chain reaction (PCR) mimicking a region of the HIV-1 LTR (dsDNA-144). Spherical gelatin microspheres were obtained by a coacervation method, showing a high percentage of encapsulation yields (over 85%). Size distribution analysis of the microspheres produced resulted in an average diameter of 22 mum. In order to analyse the release profiles of both ssDNA-44 and dsDNA-144 from microspheres, in vitro studies were carried out by using a flow-through cell method. The chemical stability of dsDNA-144 to the encapsulation procedure steps was in addition demonstrated by. PCR amplification of the DNA eluted from the gelatin microspheres. The reported results indicate that gelatin-based microspheres offer excellent potential as carrier systems for the in vivo administration of both single- and double-stranded DNA molecules.
引用
收藏
页码:181 / 186
页数:6
相关论文
共 14 条
  • [1] CROOKE RM, 1991, ANTI-CANCER DRUG DES, V6, P609
  • [2] MICROSPHERES FOR TARGETING DRUGS TO SPECIFIC BODY SITES
    DAVIS, SS
    ILLUM, L
    MOGHIMI, SM
    DAVIES, MC
    PORTER, CJH
    MUIR, IS
    BRINDLEY, A
    CHRISTY, NM
    NORMAN, ME
    WILLIAMS, P
    DUNN, SE
    [J]. JOURNAL OF CONTROLLED RELEASE, 1993, 24 (1-3) : 157 - 163
  • [3] COMPILATION OF VERTEBRATE-ENCODED TRANSCRIPTION FACTORS
    FAISST, S
    MEYER, S
    [J]. NUCLEIC ACIDS RESEARCH, 1992, 20 (01) : 3 - 26
  • [4] GAMBARI R, 1993, IN PRESS J BIOCH PHA
  • [5] NEW METHODS OF DRUG DELIVERY
    LANGER, R
    [J]. SCIENCE, 1990, 249 (4976) : 1527 - 1533
  • [6] Magenheim B., 1991, STP PHARMA SCI, V1, P221
  • [7] MIRABELLI CK, 1991, ANTI-CANCER DRUG DES, V6, P647
  • [8] TRANSCRIPTIONAL REGULATION IN MAMMALIAN-CELLS BY SEQUENCE-SPECIFIC DNA-BINDING PROTEINS
    MITCHELL, PJ
    TJIAN, R
    [J]. SCIENCE, 1989, 245 (4916) : 371 - 378
  • [9] NASTRUZZI C, 1993, IN PRESS J MICROENCA
  • [10] NECKERS L, 1992, Critical Reviews in Oncogenesis, V3, P175